BrainsWay Ltd (BRSYF PINK) stock market data APIs
$8.725
0(0%)
as of December 24, 2025
Try our APIs with
free plan!
BrainsWay Ltd Financial Data Overview
Price chart is built with
Anychart
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Prev. Close
8.725
Open
8.725
High
8.725
Low
8.725
52 wk Range
3.26-8.73
Market Cap
342 M
P/E Ratio
54.5625
Shares Outstanding
39 154 K
Revenue
49 094 K
EPS
0.0412
Beta
0.272
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BrainsWay Ltd data using free add-ons & libraries
Get BrainsWay Ltd Fundamental Data
BrainsWay Ltd Fundamental data includes:
- Net Revenue: 49 094 K
- EBITDA: 4 249 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BrainsWay Ltd News
New
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
BrainsWay Optum Behavioral Health, a Health Services Company with Over 48 Million Covered Lives, Joins Growing List of Insurers Now Covering Deep TMS Depression Therapy for Adolescents Aged 15 and Ol...
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
BrainsWay Recent agreements withtwo additional U.S. mental health providersbring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, ...
BrainsWay Announces Publication of Three New Deep TMS Research Publications
BrainsWay New Articles Enhance Understanding of Deep TMS Safety Profile and Survey Addiction Research BURLINGTON, Mass. and JERUSALEM, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE...
BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023
BrainsWay BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neuro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
